Log in to your Inderes Free account to see all free content on this page.
Active Biotech
0.06 SEK
+1.45 %
Less than 1K followers
ACTI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+1.45 %
+44.60 %
+53.41 %
+36.74 %
+5.70 %
-6.96 %
-76.17 %
-86.84 %
-98.48 %
Active Biotech operates in the pharmaceutical industry and focuses on the development of innovative treatments for cancer and autoimmune diseases. The company researches new therapies that can improve patient outcomes and quality of life. The project portfolio includes both small, orally active immunomodulatory molecules and antibody-based immunotherapy. The company operates globally. Active Biotech was founded in 1998 and is headquartered in Lund.
Read moreMarket cap
165.81M SEK
Turnover
213.98K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7.5.
2026
Interim report Q1'26
20.5.
2026
General meeting '26
20.8.
2026
Interim report Q2'26
All
Webcasts
Press releases
ShowingAll content types
NOTICE OF ANNUAL GENERAL MEETING
Annual Report 2025 Active Biotech AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio